Optimising 18 F-choline PET/CT acquisition protocol in prostate cancer patients (original) (raw)

Choline-PET in Prostate Cancer management: the point of view of the Radiation Oncologist

Critical Reviews in Oncology/Hematology, 2014

Role of 18F-Choline PET/CT in Biochemically Relapsed Prostate Cancer After Radical Prostatectomy

Clinical Nuclear Medicine, 2013

18F-choline PET/CT physiological distribution and pitfalls in image interpretation: Experience in 80 patients with prostate cancer

Ferdinando Calabria

2010

View PDFchevron_right

Influence of 11C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer

Andreas Buck

Radiotherapy and Oncology, 2011

View PDFchevron_right

18F-FACBC Compared With 11C-Choline PET/CT in Patients With Biochemical Relapse After Radical Prostatectomy: A Prospective Study in 28 Patients

Giovanni Passaretti

2013

View PDFchevron_right

Value of bimodal 18F-choline-PET/MRI and trimodal 18F-choline-PET/MRI/TRUS for the assessment of prostate cancer recurrence after radiation therapy and radical prostatectomy

Fabio Campodonico

Abdominal Imaging, 2015

View PDFchevron_right

New Acquisition Protocol of18F-Choline PET/CT in Prostate Cancer Patients: Review of the Literature about Methodology and Proposal of Standardization

Maria Cristina MArzola

BioMed Research International, 2014

View PDFchevron_right

Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience

Laura Cerezo

Cancer Imaging, 2016

View PDFchevron_right

First imaging results of an intraindividual comparison of 11C-acetate and 18F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy

Yann Seimbille

European Journal of Nuclear Medicine and Molecular Imaging, 2014

View PDFchevron_right

Value of Fused 18F-Choline-PET/MRI to Evaluate Prostate Cancer Relapse in Patients Showing Biochemical Recurrence after EBRT: Preliminary Results

mohsen farsad

BioMed Research International, 2014

View PDFchevron_right

Evaluation of Prostate Cancer with 11C- and 18F-Choline PET/CT: Diagnosis and Initial Staging

Oliver Hakenberg

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016

View PDFchevron_right

11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer

maria picchio

Journal of Nuclear Medicine, 2016

View PDFchevron_right

Early Biochemical Relapse After Radical Prostatectomy: Which Prostate Cancer Patients May Benefit from a Restaging 11C-Choline PET/CT Scan Before Salvage Radiation Therapy?

Stefano Fanti

Journal of Nuclear Medicine, 2014

View PDFchevron_right

Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer

Giorgio Saladini

Clinical Nuclear Medicine, 2013

View PDFchevron_right

Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer

Daniel Max Schmid

European Journal of Nuclear Medicine and Molecular Imaging, 2012

View PDFchevron_right

BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [ 18 F] Fluorocholine PET-CT (Phase I Study

Werner Langsteger, S.Rasoul Zakavi

View PDFchevron_right

Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer

Tobias Maurer

2013

View PDFchevron_right

Histopathological correlation of 11C-choline PET scans for target volume definition in radical prostate radiotherapy

Damien Bolton

Radiotherapy and Oncology, 2011

View PDFchevron_right

[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy

Gerhard Glatting

European Journal of Nuclear Medicine and Molecular Imaging, 2008

View PDFchevron_right

Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence

Haleem Khan

Nuklearmedizin, 2008

View PDFchevron_right

Current status of choline-PET and prostate cancer

Gary Cook

Trends in Urology & Men's Health, 2014

View PDFchevron_right

18F-choline PET/MRI: the Additional Value of PET for MRI-guided Transrectal Prostate Biopsies

Xia Shao

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016

View PDFchevron_right

Positron emission tomography for prostate, bladder, and renal cancer

Steven Larson

Seminars in nuclear medicine, 2004

View PDFchevron_right

Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer: A Systematic Review and Meta-analysis

Giorgio Saladini

Clinical Nuclear Medicine

View PDFchevron_right

10-Year Clinical Experience With 18F-Choline PET/CT

fabrizio dal moro

Clinical Nuclear Medicine, 2020

View PDFchevron_right

Choline PET/CT in recurrent prostate cancer

Sara Lucidi

Frontiers in Oncology

View PDFchevron_right

18F-choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer

Marc Coel

Annals of Nuclear Medicine, 2009

View PDFchevron_right

Optimising 18 F-choline PET/CT acquisition protocol in prostate cancer patients (original) (raw)

Related papers